| ¿µ¹® | carrier | ÇÑ±Û | º¸±ÕÀÚ, º¸ÃæÀÚ, º¸ÀÎÀÚ, ³ª¸£°³ |
|---|---|---|---|
| ¼³¸í | 1. Áõ»ó¾øÀÌ Ã¼³»¿¡ º´¿ø¹Ì»ý¹°ÀÌ Á¸ÀçÇÏ¿© °¨¿°ÀüÆÄÀÚÀÇ ¿ªÇÒÀ» ÇÏ´Â °³Ã¼. ÀÌ·¯ÇÑ °³Ã¼¸¦ º¸±Õ»óÅÂ(carrier state)¶ó ºÎ¸£°í ÀÖ´Ù. 2. ³ª¸£°³. ¼¼Æ÷³»ÀÇ ¹°Áú·Î¼ ÇѰ³ ¶Ç´Â µÎ°³ÀÇ ÀüÀÚ¸¦ ¹Þ¾Æ ȯ¿øµÇ³ª ±× ÈÄ ´Ù½Ã »ê鵃 ¼ö ÀÖ´Â °Í. 3. º¸ÀÎÀÚ. º¸Åë¿°»öü¼ºÀÌµç ¼º¿°»öü¼ºÀÌµç °£¿¡ ±× Á¤»óÀÇ ´ë¸³À¯ÀüÀÚ¿Í ´õºÒ¾î ¿¼ºÀ¯ÀüÀÚ¸¦ º¸À¯ÇÏ´Â °³Ã¼. 4. ¹æ»ç¼±Çп¡¼ ´Ù¸¥ ¹°Áú ÃßÀûÀÚ¿Í °°ÀÌ »ç¿ëµÇ¸ç, ÈÇÐÀû ¹°¸®Àû ÀÛ¿ëÀ¸·Î ±× ÃßÀûÀÚ¸¦ ¿î¹ÝÇÏ´Â ¹°Áú. 5. ¼¼Æ÷³»¸·À» ÅëÇÑ ¿î¼ÛÀÇ °æ¿ì¿Í °°ÀÌ ¾î¶² ¹°ÁúÀÌ °¡¿ª¼ºÀ¸·Î ºÎÂøÇÏ´Â ºÐÀÚ. |
||
| ¿µ¹® | vegetative state | ÇÑ±Û | ½Ä¹°»óÅ |
|---|---|---|---|
| ¼³¸í | ÀÚÀ²½Å°æ°è´Â Ȱµ¿Çϰí ÀÖÀ¸³ª ¼öÀǿÀÌ ÀüÇô ºÒ´ÉÇÑ »óŸ¦ ¸»ÇÑ´Ù. µû¶ó¼ È£Èí, ½É¹ÚÀº Áö¼ÓÇϰí ÀÖÀ¸³ª ÀǽÄÀûÀΠȰµ¿À» ÀÏÀ¸Å°´Â ÀÏÀº ÇÒ ¼ö ¾ø´Ù. ¿øÀÎÀº µÎºÎ¿Ü»ó-ôÃß¼Õ»ó-³úÇ÷°ü¼Õ»ó-³úô¼öÁ¾¾ç-Áßµ¶ µî ¿©·¯ °¡Áö°¡ ÀÖÁö¸¸, °¡Àå ¸¹Àº °ÍÀº ±³Åë»ç°í µî¿¡ ÀÇÇÑ ¸Ó¸®¿Ü»óÀÌ´Ù. ´ë³úÀÇ Ç¥ÃþºÎ´Â ´ë³ú°ÑÁúÀ̶ó Çϴµ¥, ÀÌ °÷¿¡´Â ¹é ¼ö ½Ê¾ïÀÇ ½Å°æ¼¼Æ÷°¡ ¸ð¿© ÀÖ¾î¼ ¿îµ¿-°¨°¢-ÀÇ½Ä µîÀÇ ÀÛ¿ëÀ» ´ã´çÇϰí ÀÖ´Ù. ÀÌ ´ë³ú°ÑÁúÀÇ ¼Õ»óÀ» ÀÔÀ¸¸é ¿îµ¿±â´ÉÀ̳ª ÀǽÄÀÌ Á¤ÁöµÇ°í, ³úÁٱⰡ ´ã´çÇϴ ȣÈí±â´É-¼Òȱâ´É-½ÉÀå¹Úµ¿±â´É ¹Û¿¡ ÇÏÁö ¸øÇÏ°Ô µÈ´Ù. |
||
| ¿µ¹® | persistent vegetative state | ÇÑ±Û | Áö¼Ó½Ä¹°»óÅ |
|---|---|---|---|
| ¼³¸í | ±× ºÎÀ§¿¡ »ó°ü¾øÀÌ ³ú¼Õ»ó¿¡ ÀÇÇØ¼ ÀϾ´Â °¢¼º»óÅ¿¡ ÀÖ¾î¼ÀÇ ½ÉÇÑ ¹«¹ÝÀÀ»óÅ·μ, ´ë³ú°ÑÁúÀÇ ±â´ÉÁ¤Áö, ¿ÜºÎȯ°æ¿¡ ´ëÇÑ ÀûÀýÇÑ ÀûÀÀ¹ÝÀÀÀÇ °á¿©, ¹«µ¿, ¹«¾ðÀ» Ư¡À¸·Î Çϸç, ³úÆÄ´Â ÆòÅºÈ ¶Ç´Â ÀÌ»óȰµ¿À» ³ªÅ¸³½´Ù. |
||
| ¿µ¹® | hepatitis | ÇÑ±Û | °£¿° |
|---|---|---|---|
| ¼³¸í | °£¿¡ »ý±â´Â ¿°ÁõÀ» ÅëÆ²¾î À̸£´Â ¸». ¹ß¿-Ȳ´Þ-Àü½Å±ÇÅÂ-¼ÒÈ Àå¾ÖÀÇ Áõ»óÀ» º¸À̴µ¥, ÁÖµÈ ¿øÀÎÀº À½½Ä¹°°ú Ç÷¾×À» ÅëÇÑ ¹ÙÀÌ·¯½º °¨¿°ÀÌ¸ç ±× ¹Û¿¡ ¾à¹°, ¾ËÄÚ¿Ã, ¾Ë·¹¸£±â µîÀÌ ¿øÀÎÀÎ °Íµµ ÀÖ´Ù. ÀÌ °£¿°Àº ±× Áö¼Ó±â°£¿¡ µû¶ó¼ ±Þ¼º°£¿°°ú ¸¸¼º°£¿°À¸·Î ³ª´©´Âµ¥, ¸¸¼º°£¿°Àº 6°³¿ù ÀÌ»ó °£¿°ÀÌ Áö¼ÓµÇ´Â °æ¿ì¸¦ ¸»ÇÏ°í ±Þ¼º°£¿°Àº 6°³¿ù ÀÌ»ó Áö¼ÓÇÏÁö ¸øÇÏ´Â °æ¿ì¸¦ ¸»ÇÑ´Ù. ±Þ¼º°£¿°Àº ¸·¿¬ÇÑ ¸íĪÀ¸·Î¼, °£ÀÇ ±Þ¼º-½ÇÁú¼º »óÇØÀÇ °ÅÀÇ ÀüºÎ¸¦ Æ÷°ýÇÏ´Â ³ÐÀº °³³äÀÌÁö¸¸, ½ÇÁ¦´Â ¹ÙÀÌ·¯½ºÀÇ °¨¿°À¸·Î »ý±â´Â °£¿°ÀÌ ´ëºÎºÐÀÌ´Ù. ¹ÙÀÌ·¯½º¼º °£¿°Àº À¯Ç༱°£¿°(AÇü)°ú Ç÷û°£¿°(BÇü)ÀÇ µÎ Á¾·ù°¡ Àִµ¥, À̵éÀº ¸ðµÎ Àü¿°¼º ÁúȯÀÌÁö¸¸ °¨¿° °æ·Î´Â ´Ù¸£´Ù. °¨¿° °æ·Î·Î À¯Ç༱°£¿°¹ÙÀÌ·¯½º´Â Ç÷¾×-»ùâÀÚ¾×-´ëº¯ Áß¿¡¼ Áõ¸íµÇ¹Ç·Î Àü¿°µÈ ¹°-À½½ÄÀ» ÅëÇÏ¿© °æ±¸°¨¿°µÇ°Å³ª ȯÀÚ¿ÍÀÇ Á÷Á¢ Á¢ÃË¿¡ ÀÇÇØ¼ °¨¿°µÈ´Ù. Ç÷û°£¿°Àº ¿À·ÎÁö ºñ°æ±¸Àû °¨¿°À¸·Î ȯÀÚÀÇ Ç÷û, Ç÷¾×ÀÇ ÁÖ»ç, ȯÀÚÀÇ Ç÷¾×¿¡ °¨¿°µÈ ÁÖ»ç±â µîÀ¸·Î °¨¿°µÈ´Ù. Àẹ±â´Â À¯Ç༺°£¿°ÀÌ 2~6ÁÖ°£À̰í, Ç÷û °£¿°Àº 6ÁÖ~6°³¿ù °¡·® µÈ´Ù. Ç÷û°£¿°Àº À¯ÇàÀÇ °èÀý-¿¬·É°ú´Â °ü°è°¡ ¾øÀ¸³ª, À¯Ç༺°£¿°Àº ÁÖ·Î °¡À»¿¡¼ °Ü¿ï¿¡ °ÉÃÄ ¸¹°í û¼Ò³â¿¡ ¸¹´Ù. Áõ¼¼´Â ¹ßº´Çϱâ 1ÁÖÀÏ ÀüºÎÅÍ ¿Â¸öÀÌ ³ë°ïÇÏ°í ½Ä¿åÀÌ ¶³¾îÁö¸ç µÎÅëÀÌ ÀÖ°í »óº¹ºÎ¿¡ ºÒÄè°¨ÀÌ »ý±â´Âµ¥, À¯Ç༺°£¿°¿¡¼´Â Ȳ´ÞÀÌ ³ªÅ¸³ª±â Àü¿¡ ¹ß¿(38¡É ÀüÈÄ)ÀÌ ÀÖÀ» ¶§°¡ ¸¹°í ¼öÀÏ ÈÄ¿¡ ÇØ¿µÈ´Ù. ¶Ç, °üÀý-Ç㸮°¡ ¾ÆÇà ¶§µµ ÀÖ¾î óÀ½¿¡´Â °¨±â·Î ¿ÀÀÎÇÒ ¶§°¡ ¸¹´Ù. Ç÷û°£¿°Àº ÀÌ·¯ÇÑ Ãʱâ Áõ¼¼°¡ °¡º±°í ¼¼È÷ ¹ßº´ÇÏ´Â °ÍÀÌ ¸¹´Ù. ÁÖÁõ¼¼´Â À§ÀåÁõ¼¼¿Í Ȳ´ÞÀ̸ç, ½Ä¿åºÎÁø-±¸Åä-±¸¿ªÁú, »óº¹ºÎÀÇ µÐÅë µîÀÌ ÀϾ¸ç, ¹ßº´ ÈÄ 4~5ÀÏ¿¡ Ȳ´ÞÀÌ ³ªÅ¸³´Ù. Ȳ´ÞÀº 1ÁÖÀÏÀ» ÀüÈÄÇÏ¿© ÃÖ°í¿¡ À̸£¸ç, ±× ÈÄ 1°³¿ù »çÀÌ¿¡ ¾ø¾îÁö¸é¼ ´Ù¸¥ Áõ¼¼µµ ÁÁ¾ÆÁø´Ù. °æ°ú´Â ±Þ¼º°£¿°Àº ¾à 70%°¡ ´ë°³ 1~3°³¿ù À̳»¿¡ Ä¡À¯µÇÁö¸¸ »¡¸® Ä¡·áµÇÁö ¾Ê´Â °Í Áß 15%°¡ ¸¸¼º°£¿°À¸·Î ÀÌÇàÇϸç, ±× ÀϺδ °£°æÈÁõÀ¸·Î ÀÌÇàÇÑ´Ù. ±Þ¼º°£¿° Áß¿¡´Â ¶§·Î´Â 10ÀÏ À̳»¿¡ »ç¸ÁÇÏ´Â Àü°Ý¼º°£¿°À̶ó°í ÇÏ´Â °Íµµ ÀÖ´Ù. º´ÀÇ Àüü °æ°ú Áß È²´ÞÀÌ ³ªÅ¸³ªÁö ¾Ê´Â ¹«È²´Þ¼º °£¿°À̶ó°í ÇÏ´Â °Íµµ ÀÖ¾î. ¸¸¼º°£¿°À¸·Î ÀÌÇàÇÏ´Â °Í¿¡´Â ÀÌ ¹«È²´Þ¼ºÀÌ ¸¹Àº °æÇâÀÌ ÀÖ´Ù. Ç÷û°£¿°µµ ¸¸¼ºÈÇϱ⠽±´Ù. |
||
| ¿µ¹® | acute hepatitis | ÇÑ±Û | ±Þ¼º°£¿° |
|---|---|---|---|
| ¼³¸í | ¹ÙÀÌ·¯½º¿¡ ÀÇÇØ °£¿¡ »ý±â´Â ±Þ¼º¿°Áõ. ±Þ¼º°£¿°À̶õ °£¿°¹ÙÀÌ·¯½º(AÇü-BÇü-ºñAºñBÇü)¿¡ ÀÇÇØ¼ °£¿¡ »ý±â´Â ±Þ¼º¿°ÁõÀ» º´¸íÀ¸·Î À̸£´Â ¸»·Î, ÀÌ´Â ±× °¨¿°¾ç½Ä¿¡ ¼öÇ÷ ÈÄ¿¡ ¹ß»ýÇÏ´Â ¼öÇ÷ÈÄ °£¿°°ú, °¨¿°°æ·Î¸¦ ¾Ë ¼ö ¾ø´Â »ê¹ß¼º°£¿° ¹× Áý´ÜÀ¸·Î ¹ß»ýÇÏ´Â À¯Ç༱°£¿°ÀÇ ¼¼°¡Áö À¯ÇüÀ¸·Î ³ª´ ¼ö ÀÖ´Ù. ¼öÇ÷ÈÄ °£¿°Àº ±× 95%°¡ ºñAºñBÇü°£¿°ÀÌ¸ç ³ª¸ÓÁö°¡ BÇü °£¿°ÀÌ´Ù. »ê¹ß¼º °£¿°Àº AÇü °£¿°°ú BÇü °£¿°ÀÌ °¢°¢ 30%¸¦ ÀÌ·ç°í ³ª¸ÓÁö 40%´Â ºñAºñB°£¿°ÀÌ´Ù. Áý´ÜÀ¸·Î ¹ß»ýÇÏ´Â À¯Ç༺°£¿°Àº °ÅÀǰ¡ AÇü°£¿°ÀÌÁö¸¸ ¶§·Î´Â ¿©±â¿¡ Æ÷ÇÔµÇÁö ¾ÊÀº ÇüÀÇ °£¿°ÀÏ °æ¿ìµµ ÀÖ´Ù. ±Þ¼º°£¿°ÀÇ Áõ¼¼´Â ¸ÕÀú ¸öÀÌ ³ª¸¥ÇØÁö°í ¿Â¸ö¿¡ ±ÇۨÀÌ Ã£¾Æ¿À¸ç Á¶±×¸¶ÇÑ ÀÏ¿¡µµ °ð ÇǷθ¦ ´À³¢°Ô µÈ´Ù. ±×¸®°í ½Ä¿åºÎÁø-¹ß¿-±¸ÅäÁõ-º¹Åë-¼³»ç µî, °¨±â³ª ±Þ¼ºÀ§Àå¿°¿¡ °É·ÈÀ» ¶§¿Í °°Àº Áõ¼¼ µîÀÌ ³ªÅ¸³´Ù. µÚÀ̾î Ȳ´ÞÁõ¼¼¸¦ º¸À̴µ¥, À̶§´Â ÃʱâÀÇ Áõ¼¼°¡ ¾à°£ °¡º¿öÁø °Íó·³ ´À²¸Áö´Â °ÍÀÌ º¸ÅëÀÌ´Ù. ±×·¯³ª Ȳ´ÞÁõ¼¼°¡ ½ÉÇØÁö°í ÃʱâÀÇ Áõ¼¼µéÀÌ ´Ù½Ã ÁøÇàµÇ¸é À̶§´Â Àü°Ý¼º°£¿°ÀÌ µÉ À§ÇèÀÌ ÀÖ´Ù. °£¿° Áõ¼¼°¡ ½ÉÇÏÁö ¾Ê¾ÒÀ» °æ¿ì´Â Ȳ´ÞÀÌ ´«¿¡ ¶çÁö ¾ÊÀº °æ¿ìµµ Àִµ¥ À̶§´Â ÁøÂûÀ» ÇØµµ °¨±â³ª ±Þ¼ºÀ§Ã¢ÀÚ¿°À¸·Î ÀÚÄ© ¿ÀÁøµÇ±â ½±´Ù. ¶Ç AÇü°£¿°Àº ¿ÀÌ 38~39¡É±îÁö ¿À¸£°í Áõ¼¼°¡ °©Àڱ⠳ªÅ¸³ª´Â °ÍÀÌ Æ¯Â¡ÀÌ¸ç ±Þ¼ººñAºñBÇü°£¿°Àº Áõ¼¼°¡ ºñ±³Àû °¡º¿î °ÍÀÌ Æ¯Â¡ÀÌ´Ù. ±Þ¼ºBÇü°£¿°ÀÇ Áõ¼¼´Â AÇü°£¿°°ú ±Þ¼ººñAºñBÇü°£¿°ÀÇ Áß°£ Á¤µµÀÎ °ÍÀÌ º¸ÅëÀÌ´Ù. |
||
| AH | abdominal hysterectomy; absorptive hypercalciuria; accidental hypothermia; acetohexamide; acid hydro... |
|---|---|
| LES | Lambert-Eaton syndrome; Lawrence Experimental Station [agar]; local excitatory state; Locke egg seru... |
| SH | Salter-Harris [fracture]; Schonlein-Henoch [purpura]; self-help; serum hepatitis; sexual harassment;... |
| CAH | chronic active hepatitis; chronic aggressive hepatitis; combined atrial hypertrophy; congenital adre... |
| HA | H antigen; Hakim-Adams [syndrome]; halothane anesthesia; Hartley [guinea pig]; headache; health alli... |
| AAC | ADP-ATP carrier |
|---|---|
| ACP | Acyl Carrier Protein |
| ACP | Acyl-acyl carrier protein |
| acyl-ACP | Acyl-acyl carrier protein |
| ACP | Beta-Ketoacyl-acyl carrier protein |
| carrier state | A condition in which a human who is not himself sick harbors an infective organism which may cause disease in those to whom it is transmitted. (12 Dec 1998) |
|---|---|
| acetoacetyl-acyl carrier protein synthase | <enzyme> E coli enzyme, that catalyses condensation of malonyl-acyl carrier protein plus acetyl-acyl carrier protein; not inhibited by cerulenin Registry number: EC 2.3.1.- Synonym: acetoacetyl-acp synthase (26 Jun 1999) |
| acyl-(acyl-carrier-protein)-phospholipid acyltransferase | <enzyme> Catalyses the formation of phosphatidylethanolamine from acyl-acyl carrier protein and 2-acyl-sn-glycero-3-phosphoethanolamine Registry number: EC 2.3.1.40 Synonym: 2-acyl-gpe acyltransferase, 2-acylglycerophosphoethanolamine acyltransferase (26 Jun 1999) |
| acyl-(acyl-carrier-protein)-UDP-N-acetylglucosamine acyltransferase | <enzyme> E coli enzyme involved in lipid a biosynthesis; uses beta-hydroxymyristoyl-acyl carrier protein to form udp-3-monoacyl-n-acetylglucosamine; amino acid sequence given in second source Registry number: EC 2.3.1.129 Synonym: udp-aguatransferase, lpxa protein, udp-n-acetylglucosamine-3-acyltransferase, udp-n-acetylglucosamine 3-o-acyltransferase, udp-3-o-(r-3-hydroxymyristoyl)glucosamine-n-acyltransferase, lpxd protein, fira gene product, fira protein (26 Jun 1999) |
| acyl carrier protein | <protein> A small (77 peptides long) protein which binds six other enzymes involved in fatty acid synthesis. It was first isolated in E. Coli bacteria. (09 Oct 1997) |
| acyl carrier protein acylase | <enzyme> From E coli Registry number: EC 2.3.1.- Synonym: acp acylase (26 Jun 1999) |
| amalgam carrier | An instrument used to transport triturated amalgam to a cavity preparation and to deposit it therein. (05 Mar 2000) |
| beta-hydroxyacyl-(acyl-carrier-protein)dehydrase | <enzyme> In fatty acid synthesis; specific for acyl carrier protein; cannot use acyl CoA; see also faba gene product Registry number: EC 4.2.1.- Synonym: beta-ohacyl-acp dehydrase, beta-hydroxyacyl-acyl carrier protein dehydratase, fabz gene product (26 Jun 1999) |
| galactose-diphosphoglycosyl carrier lipid synthetase | <enzyme> Catalyses synthesis of gcl-pp-gal from udp gal and p-gcl; also catalyses exchange between the uridylyl moiety of udpgal and ump Registry number: EC 2.4.1.- (26 Jun 1999) |
| malonyl-CoA-acetyl CoA-acyl carrier protein S-acyltransferase | <enzyme> Specific for either malonyl-CoA or acetyl-CoA; a component of fatty acid synthase Registry number: EC 2.8.3.- Synonym: mcoa-acoa acp acyltransferase (26 Jun 1999) |
| manifesting carrier | An organism heterozygous for what is ordinarily a recessive condition which, as a result of special mechanisms (such as lyonization, allelic exclusion, or a deletion in the homologous chromosome), has phenotypic manifestations. Synonym: manifesting carrier. (05 Mar 2000) |
| genetic carrier | An unaffected heterozygote bearing a usually harmful recessive gene, a cancer that bears a dominant but latent age-dependent trait to have offspring with unbalanced karyotypes. (05 Mar 2000) |
| carrier | 1. <genetics, microbiology> An individual who does not display the symptoms of a disease, but harbors the pathogen which causes it, or has the gene (or genes) for it, and can transmit the disease to others either through interacting with other individuals, or by passing the disease-causing gene (or genes) to offspring. 2. <pharmacology> A substance which transports things, such as a carrier protein. (09 Oct 1997) |
| carrier cell | <cell biology> A cell that is capable of phagocytosis. The main mammalian phagocytes are neutrophils and macrophages. Origin: L. Phagedaena, Gr Phago, To eat. (18 Nov 1997) |
| carrier electrophoresis | Electrophoresis done on a carrier (such as paper, polyacrylamide gel, etc.). (05 Mar 2000) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|